Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 442-680-5 | CAS number: 443688-20-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 18th to July 26th, 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- a guinea pig maximisation test is already available
Test material
- Reference substance name:
- Red LF 6339
- IUPAC Name:
- Red LF 6339
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Biotechnology and Animal breeding Division, Wolferstrasse 4, CH-4414, Fullinsdorf
- Age at study initiation: 3-6 weeks
- Weight at study initiation: 385-420 g (pre-test), 304-437 g (beginning of acclimatisation period)
- Housing: individually in Makrolon type-4 cages with standard softwood bedding
- Diet (e.g. ad libitum): pelleted standard Provimi Kliba 3418 guinea pig breeding/maintenance diet containing vitamin C, ad libitum
- Water (e.g. ad libitum): community tap water, ad libitum
- Acclimation period: one week under test conditions after health examination. No acclimatization for the animals of the pretest
ENVIRONMENTAL CONDITIONS
- Temperature: 20±3 °C
- Humidity: 30-70 %
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 300
- Concentration / amount:
- 5 % (intradermal)
50 % (epidermal) - Day(s)/duration:
- day 1 (intradermal); day 8 (epidermal)
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- No.:
- #1
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 300
- Concentration / amount:
- 10 %
- Day(s)/duration:
- Day 22
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 15 (10 test and 5 control)
- Details on study design:
- VEHICLE
Polyethylene glycol (PEG 300)
TEST ITEM PREPARATION: the test item and vehicle or auxilliary compound were placed into a glass beaker and a weight by weight dilution was prepared.
SELECTION OF CONCENTRATION OF TEST ITEM FOR MAIN TEST
- Intradermal induction: the 5 % concentration of test item used for the intradermal induction exposure was well-tolerated systemically and was the highest technically applicable concentration
- Epidermal Induction: the 50 % concentration of test item used for the epidermal induction exposure was well-tolerated systemically and was the highest technically applicable concentation causing milk skin irritation
- Epidermal challenge: the 10 % concentration of the test item used for the challenge application was the maximum tested non-irritant concentration.
PRETEST:
- Intradermal injections: four intradermal injections (0.1 ml/site) of a 1:1 (v/v) mixture of Freud's Complete Adjuvant/physiological saline were made into the shaved neck of one guinea pig. One week later intradermal injections (0.1 ml/site) were made into the clipped flank of the same guinea pig at concentrations of 5 %, 3 % and 1 % of the test item in PEG 300. Dermal reactions were assessed 24 hours later. The test item concentration of 5 % was selected for intradermal induction in the main study.
- Epidermal applications: four intradermal injections (0.1 ml/site) of a 1:1 (v/v) mixture of Freud's Complete Adjuvant/physiological saline were made into the shaved neck of two guinea pigs. One week later both flanks of each of the guinea pigs were clipped and shaved just prior to the application. Thereafter 4 patches of filter paper were saturated with the test item at 50 %, 25 %, 15 % and 10 % in PEG 300 and applied to the clipped and shaved flanks. The patches were covered by a strip of aluminium foil and firmly secured by elastic plaster wrapped around the trunk and covered with imprevious adhesive tape. The dressings were removed after an exposure period of 24 hours. Twenty-one hours after removal of the dressing, the applicatio site was depilated with an approved depilatory cream in order to visualize any resulting erythema. The depilatory cream was placed on the patch sites and surrounding areas and left on for 3-5 minutes. It was then thoroughly washed off with a steam of warm, water. The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema.
MAIN STUDY
A. INDUCTION EXPOSURE
A.1 INTRADERMAL INJECTIONS
- No. of exposures: 3 pairs of intradermal injections
- Test groups: 1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline, 2) the test item at 5 % in PEG 300, 3) the test item at 5 % in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline
- Control group: 1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline, 2) PEG 300, 3) 1:1 (v/v) mixture of PEG 300 in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline
- Site: area of dorsal skin from the scapular region
A.1 EPIDERMAL APPLICATIONS
- Exposure: one week after the injections
- Test groups: a patch of filter paper was saturated with the test item (50 % in PEG 300) and placed over the injection sites of the test animals. The patch was covered for an ensured intensive contact of the test item.
- Control group: treated as the test group but only with PEG 300.
- Site: area of dorsal skin from the scapular region
- Evaluation of the sites: 24 and 48 hours after removal of the bandage for erythema and oedema.
B. CHALLENGE EXPOSURE
- Day(s) of challenge: two weeks after the epidermal induction application.
- Exposure period: 24 hours
- Test groups and control groups: two patches of filter paper were saturated with the test item (10 % in PEG 300) applied to the left flank and the vehicle only (PEG 300 applied to the right flank) using the same method as for the epidermal application. The patch was covered for an ensured intensive contact of the test item.
- Site: left and right flank of each guinea pig
- Concentrations: 10 %
- Evaluation (hr after challenge): 24 and 48 hours after removal of the bandage for erythem and oedema according to the method of Magnusson and Kligman.
OBSERVATIONS
- Viability/Mortality: daily from delivery of the animals to the termination of the test
- Clinical signs: daily from delivery of the animals to the termination of the test
- Skin reactions: at the times specified durinh the pretest, induction and challenge periods
- Body weights: at pretest and acclimatization start, day 1 and termination of the test - Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamaldehyde
Results and discussion
- Positive control results:
- 100 % and 60 % positive responses at 24 and 48 h readings in test group.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- test item in 10 % in PEG 300 (left flank) and PEG 300 only (right flank)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no clinical signs and no mortality
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- test item in 10 % in PEG 300 (left flank) and PEG 300 only (right flank)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no clinical signs and no mortality
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- induction at 10 % (intradermal and epidermal); challenge at 0.1 % (epidermal)
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
- Intradermal induction: erythema, oedema, necrotizing dermatitis, encrustration, exfoliation of encrustation and violet discoloration
- Epidermal induction: control group- no erythematous or oedematous reaction was observed in the animals treated with PEG 300 only. Test group- the test item stained the skin violet and it was not possible to determine whether erythema was present or no. No oedema was observed. The animals were not depilated in the epidermal induction phase.
- Challenge: control group- no skin reactions in the animals treatd with either PEG 300 only or when treated with the test item at 10 % in PEG 300. Violet discoloration produced by the test item was noted directly after removal of the patch. Test group- no skin reactions in the animals treatd with either PEG 300 only or when treated with the test item at 10 % in PEG 300. Violet discoloration produced by the test item was noted directly after removal of the patch.
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified as a skin sensitiser according to the CLP Regulation (EC) No.1272/2008
- Conclusions:
- not skin sensitiser
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.